Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners.
Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala Capital Ventures. According to Crunchbase, Unlearn's total raise now totals nearly $70 million.
Unlearn uses a machine learning model to create digital twins of randomized controlled trial...
Unlearn, a startup creating digital twins used in the control arm of clinical trials, announced today an extension to its Series A funding round, bringing the total amount raised to $15 million.
New investors Eisai, Epic Ventures and Alumni Ventures Group contributed to the oversubscribed round. They join 8VC, DCVC, DCVC Bio and Mubadala Capital Ventures, which contributed to Unlearn’s original...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
